FindTrial
Sign In

The study of changes of nerve thickness of eye after reducing eye pressure by 25% with Bimatoprost 0.03% eyedrops vs artificial tear eyedrops.

The study of changes of Bruchâ??s opening parameters after IOP reduction by 25% with topical Bimatoprost 0.03% vs placebo in glaucoma suspect patients: A Randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049300
Enrollment
44
Registered
2023-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H400- Glaucoma suspect

Interventions

Intervention1: Eyedrop Bimatoprost 0.03%: Glaucoma suspect in intervention group will be prescribed Eyedrop Bimatoprost 0.03% once daily at bedtime for 6 months Control Intervention1: Eyedrop Carboxym

Sponsors

All India Institute of Medical Sciences Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Any disc suspect patient of age 35-60 years with positive family history 2) Open angles on gonioscopy 3) IOP is below 21 mm of Hg 4)BMO MRW changes on OCT 5)Normal visual fields on 24-2 program

Exclusion criteria

Exclusion criteria: 1)Not giving consent for participation 2) Any congenital disc anomaly 3)Closed angles 4) History of any intervention to control IOP in past 5) Abnormal visual fields 6)Any systemic illness severe enough to hamper examination and follow ups

Design outcomes

Primary

MeasureTime frame
Global Bruchs membrane opening parameter changesTimepoint: 1) Three months followup and 2) Six months followup—

Secondary

MeasureTime frame
Six Sectoral Bruchs membrane opening parameter changesTimepoint: 1) Three months followup and 2) Six months followup—

Countries

India

Contacts

Public ContactDr Amit Raj

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, PATNA

drbchandra@gmail.com9973231580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026